Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Abuse Withdrawal Supplement Marketers Warned, Claims And Sales Continue

Jan 25 2018

Related Content

Kratom Supplement Marketers Dispute FDA Warning, Ask For Review

Nov 16 2017

Opiate Addiction Remedy Claims Could Face FTC Substantiation Test

Nov 06 2017

Opioid-Withdrawal 'Aids' Warrant Immediate FDA, FTC Action – CSPI

Dec 15 2017

Additional Topics

United States US States Dietary Supplements Advertising, Marketing & Sales Regulation Respiratory Poisoning Neurology Inflammation Immune Disorders Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window